Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引：0

作者：

Guitti Pourdowlat

Seyed Ruhollah Mousavinasab

Behrooz Farzanegan

Alireza Kashefizadeh

Zohreh Akhoundi Meybodi

Maedeh Jafarzadeh

Shadi Baniasadi

机构：

[1] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),Chronic Respiratory Diseases Research Centre

[2] Shahid Beheshti University of Medical Sciences,Department of Clinical Pharmacy, Faculty of Pharmacy

[3] Shiraz University of Medical Sciences,Tracheal Diseases Research Centre

[4] Critical Care Quality Improvement Research Centre,undefined

[5] SBMU,undefined

[6] Shahid Dr. Labbafinejad Hospital,undefined

[7] Shahid Beheshti University of Medical Sciences,undefined

[8] Shahid Sadoughi University of Medical Sciences,undefined

[9] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),undefined

[10] Shahid Beheshti University of Medical Sciences,undefined

来源：

Trials | / 22卷

关键词：

COVID-19; hypoxia; inhalation; magnesium sulphate; protocol; randomised controlled trial; respiratory tract symptoms;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用